[Treatment of lymphosarcoma by the triple combination vincristine-rubidomycin-prednisone].
D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use*; D002648:Child; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy*; D015122:Mercaptopurine / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use*; D014750:Vincristine / Q000627:therapeutic use*
D000903:Antibiotics, Antineoplastic; D014750:Vincristine; D015122:Mercaptopurine; D011241:Prednisone; D008727:Methotrexate
Traitement des lymphosarcomes par la triple association vincristine-rubidomycine-prednisone.